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SUCCESSFUL ERRORS AND OTHER ODD WAYS
TO NEW DISCOVERIES*
by
F. LEMBECK
MEDICALRESEARCH tends moreand moreto become atechnical process. This includes
not only the technical equipment of our laboratories, but also the co-operation of
specialists coming from different fields ofmedicine and natural science. Co-operation
affords organisation and administration. When such work has to be done by a
scientist, he has to leave the laboratory and occupy chairs on committees. This may
severelychange his outlook on scientific life and productivity, a fact which Anne Roe
recently brought to our notice in an interesting comment in Science.
Governments and other organizations develop research programmes and think in
terms ofnew buildings, offinancial support and ofthe publication ofresults. These
basic prerequisites are certainly essential to research programmes. Scientists must
become accustomed to co-operate in such programmes. Large programmes are often
very successful; forexample, the search forantimalarial drugs or the screening ofnew
antibiotics and their clinical trials. Under such conditions the specialists confronted
with a specific problem become a team, often a very effective one, and not a 'lost
legion' as the occasionally large number ofscientists involved in a single programme
in physics or technology have been called.
Thisgeneralpictureoflarge-scaleresearchmay,however, alsochange ourindividual
approach to research problems. Some very original characteristics of the men who
formerly undertook 'one-man expeditions' may be lost, but, at each stage, and each
time research is attempted, completely unexpected results may occasionally be
obtained. During a planned research programme which has to reach a certain goal
such side-effects of research may easily be neglected. We in university laboratories
are relatively free from an excessive amount ofprogramming, but a drawing from an
industrial firm can show you the seven years of intrauterine development of a new
drug. Itincludesthefunctionofthepharmacologist, notunlikethatofatransferRNA,
whoselectschemicalinformationandcarriesittothetherapeuticapplication. Previous
'findings' have been transformed into 'constructions' like an aircraft or a bridge, as
we see when we look at the final result.
Ideas whichbyway ofexperimentlead to newdiscoveries arestimulated in different
ways:
1) Nature itself offers many examples of models for later technical application: An
aircraft looks and glides like a bird. Even the wing mechanism of a helicopter is
mechanically equivalent to the wing and feather movements of a bird when it is
fluttering. 2) Other discoveries are purely the result of the human brain: Circular
movements occur in Nature, but the wheel has been found only above a certain level
of civilisation, and, for instance, was not familiar to the otherwise intelligent and
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skilful Maya. 3) Many physical or chemical processes are used by living organisms:
their mechanism could not be readily understood by the human mind before their
physical or chemical basis had been established. In some instances these processes
had been put to technical use before it was recognized that they were also in natural
use. Ultrasonic echo waves were already being used in commercial fisheries when it
was discovered that bats used them for orientation. Even the modern fluid-propelled
rockets have their involuntary predecessors in Nature. The insects of the species
Brachynus Bombardier beetle produce a 25 per cent solution of hydrogen peroxide
and hydroquinonein a gland and collect this mixturein a bladder. A valve opened by
a muscle allows the mixture to enter a chitin shielded sort of combustion chamber.
Here an explosive catalytic reaction produces quinone and liberates oxygen which
expels thefluidthrough an outletvalve atveryhigh speed. 4) Occasionally, adiscovery
is the result ofan incidental mistake or the neglect ofrules. Blotting paper, now used
in the advanced form offilter paper for chromatography, was first produced because
someone forgot to add glue to the paper pulp, whereupon he was dismissed from the
paper mill. The discovery of Ringer solution occurred because Ringer's technician
found the London tap water as good as distilled water forpreparing asaline solution.
During his technician's absence, Ringer made saline himself and involuntarily
observed that distilled water was not as good as the water which the technician had
used.
On the way from a hypothesis to a new discovery three possibilities occur:
1) We know examples of a profound idea resulting in clear experimental evidence.
This may be regarded as the straight line of success. 2) We also know that a correct
hypothesis is not necessarily successfully proven by experimental evidence. 3) Finally,
quite unexpected results may appear without any connection to the original
hypothesis.
As an example ofthe first possibility consider Paul Ehrlich's drawings of'Hapto-
phore' and 'Toxophore Gruppen'; these 'schone Figuren' are even now, when we
study molecular aspects of receptor-drug interactions, of impressive value.
To illustrate the second possibility we can cite Zulzer who, earlier than Best and
Banting, had probably discovered the right method of extracting insulin from the
pancreas, but he injected too much ofhis extract into the rabbits and they died from
convulsions.
Feyrter, very early, had the idea that carcinoids liberate an active endocrine sub-
stance; but from post-mortem findings he could not reconstruct the clinical picture
ofthe carcinoid syndrome. He recommended theinjection ofa carcinoid extract into
an animal. This led to a blood pressure response in the cat which suggested the
presence of an adrenaline-like compound. When he carried out a post-mortem
examination of a carcinoid case he sent his assistants to the relatives ofthe case to
enquire about his life and possible symptoms. Fromthese enquiries hededucedsome
connection between carcinoids and alcoholism. (I personally think that many of
these cases had a red face or a flush which was most likely to be explained by the
relatives as a result ofa high alcohol consumption.)
Another example of this kind is seen in the work of Laland and Klem who, as
early as 1939, produced a very refined preparation of the anti-pernicious anaemia
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factor. At that time further work was interrupted. A sample oftheir preparation was
placed on a slide under a cover glass. Nineteen years later, others put this slide under
a microscope and observed the typical red crystals ofcyanocobalamin.
As for the third possibility, in recent years there have been so many straight lines
from the hypothesis to the expected result that this is now the most usual procedure.
I want, however, to present a strange collection of examples in which discoveries
have been made on the basis of wrong assumptions, neglected facts, incidental
events-in short, where the success ofthe research depended on some sort oferror in
the planning, the work, or the conclusions.
Before 1900 Liebermann introduced phenolphthalein for masking the colour of
adulterated wines made from the husks ofgrapes. This colouring prevented the wine
from beingmixed and sold with wines ofgood quality. 10 mg. ofphenolphthalein per
litre ofwineis sufficient to give a deepred colour upon addition ofsodiumhydroxide.
Vanossy in Budapest thereafter performed a chronic toxicity test ofphenolphthalein
by using three rabbits and giving 30, 100 and 200 mg. daily for two months. When he
was thoroughly confident that the substance was harmless to animals, he gave it to
'healthy men, first of all himself' in the dose of 1.5 gm. This led to the discovery of
its laxative action. But he stated 'in the interest of alcoholics', that the addition of
10 mg./litre ofwine can be regarded as safe, 'even when 5-10 litres ofwine are con-
sumed daily'. Phenolphthalein has a laxative effect only in man and monkeys and it
was not until 1941-48 that Loewe investigated a number of structural analogues in
Rhesus monkeys. It was probably an error to look for protection of the alcoholics
from wines ofbad quality by adding phenolphthalein, but the use ofphenolphthalein
turned out to be ofconsiderable help in treating constipation.
Disulfiram (Antabuse) has been used for years in the rubber industry as an anti-
oxidant. It was also used as a skin disinfectant and as a fungicide. Hald, Jacobson
and Carsen (1948) performed animal experiments and toxicity studies to introduce
disulfiram as an anthelmintic. Stimulated by the low toxicity in animals they per-
formed an experiment on themselves and enjoyed the apparent absence of toxic
effects. Then, it has been told, they went to a cocktail party-thereafter feeling quite
intoxicated. They knew the similar hypersensitivity to alcohol after contact with
cyanamide or ingestion of the fungus Coprinus atramentarius, but the smell of
acetaldehyde led them subsequently to find the mode ofaction ofdisulfiram. I think
this is a remarkable success for all those who succumb to the error of regarding
large doses of alcohol as an essential foodstuff.
According to Straub's version, Jarisch, the late pharmacologist of Innsbruck, felt
that he belonged to the lower species ofpharmacologists, those who use drugs only
to explore physiological functions. One day he wished to advance to the higher
species of pharmacologists who use experiments to discover the therapeutic action
ofa drug. He found himselfimpressed by some old reports about an antihypertensive
effect of mistletoe (Viscum album) and chose to investigate it. He prepared extracts
ofit and observed alowering ofthe blood pressure, which was at that time accounted
for by some others by a presumed occurrence of acetylcholine in mistletoe. He re-
vealed the reflex mechanism of mistletoe extracts on the heart. During the grinding
of the mistletoe powder in preparing the extract, his co-worker, Henze, frequently
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had to sneeze. Since sneezing is also a reflex, Jarisch looked into some olderliterature
concerning Veratrum (which is called 'sneeze root' in German) and found the almost
forgotten cardiac reflex observed by Bezold in 1867 after injection of Veratrum
extracts. Theseinvestigations ledto thedetailed description ofthewell-knownJarisch-
Bezold reflex. In other words, Jarisch failed to moveup to the so-called higher species
of pharmacologists, but successfully used mistletoe to discover an important reflex
mechanism.
Concerning the detection of the Dale-Schultz reaction, the best I can do, is to
refer to Sir Henry Dale's own words:
I had become familiar, in other connections, with the use of the isolated uterus of the virgin
guinea-pig as a sensitive sample of unstriated muscle. I was using it for some not immediately
fruitful comparisons of the stimulating activity of freshly separated blood sera, of which horse
serum was the one most easily available to me, with that ofhistamine; and thus I encountered
a uterus, from a particular guinea-pig, which contracted rapidly and to a mimal extent in
response to afirst application ofhorse serum, in anormallyquiteinactive dilution. I wasworking
in a laboratory in which many guinea-pigs were, of course, being used for assays of antitoxin,
involving very small injections of horse serum; and I naturally remembered Theobald Smith's
discovery, a few years earlier, ofanaphylaxis to horse serum in guinea-pigs which had recovered
from such tests. My then young colleague, A. T. Glenny, was in charge of this serum testing,
and for that reason I had made him responsible for the supply of guinea-pigs to all users.
Enquiry immediately confirmed my suspicion; Glenny had supposed that a guinea-pig surviving
from an antitoxin test would be 'good enough' for my 'pharmacological experiments!'
This could not have happened in a laboratory where only fresh animals were used in
every experiment.
After his famous Africa expedition in 1865, Livingstone reported on an arrow
poison made from Strophanthus seeds. Kirk, who was one of his companions, first
noticed its cardiac action. For some unknown reason Kirk's toothbrush became
contaminated with this poison. He noticed the bittertasteand assumed a contamina-
tion with quinine. But then he observed cardiac effects and bradycardia.
The subsequent investigation by Sharpey and his co-workers revealed its digitalis-like
action. Sir Thomas Fraser performed comprehensive pharmacological and clinical
studies. But it was not before 1906, that a practitioner in Baden, Germany, Albert
Friinkel, introduced-against the advice ofSchmiedeberg-intravenous Strophanthin
therapy in themedical clinic ofHeidelberg. We as humanbeings livinginlaboratories
would probably say that it was rather careless that a toothbrush became contamin-
ated with an arrow poison. But what a lucky accident!
The antifibrillatory action ofquinine was first reported by Wenckebach in 1914 but
was described by a patient:
... In 1912, apatient presented himselfin my office wishing to get rid ofhis attacks ofauricular
fibrllation ... On mytelling him that I could promise nothing, he told me that he knew himself
how to get rid ofhis attacks but I did not believe him. He promised to come back next morning
with a regular pulse, and he did ... I was greatly struck by this fact and afterwards tried this
treatment on many cases ofauricular fibrillation. My success was disappointing, in that quinine
abolished auricular fibrillation in only a few cases, and in these cases only when the onset was
quite recent, never when it was of several years duration.
Critical people may regard the patient as the real discoverer. We may, however, sub-
mit that the reputation of Wenckebach as a clinician encouraged the patient to tell
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him about his secret remedy. This illustrates how successful a physician can be when
he carefully listens to unexplained and often confusing reports of a patient.
Domagk, Klarer and Mietsch observed in 1932 that mice with streptococcal
infection could be protected by the azo-dye prontosil. This compound had been
developed in a series of azo-dyes. As early as 1903 Hoerlein synthesized the first
colour-fast dyestuff with a sulphonamide group. The combination of azo-dyes with
proteins led to the search for further substances which react with bacterial proteins.
The bactericides chrysoidine, pyridium and scarlet red were found and the last two
substances appliedin man. Theliberation ofan active sulphonamide fromchrysoidine
waspostulated, thehigh bactericidal action wasnoted, buttheresearch was continued
on the line of azo-dyes. Work on the azo-compounds achieved success with the
important discovery ofprotonsil rubrum in 1932. It subsequently turned out to be an
errortobelievethatthe 'azo' groupwasresponsiblefortheeffect, asin 1936Fourneau
discovered that sulphanilamide (protonsil album) was the active group in protonsil
rubrum. He thereby gave a new and promising direction for further experimentation.
A similar comment could be made on the discovery of anti-emetics among anti-
histamines, Monoamine oxidase inhibitors among tuberculostatics, saliuretics and
antidiabetic drugs among sulphonamides, and the taeniacidal effect of atebrin.
The members ofthe philosophical society of Socrates were forbidden to eat Vicia
fava beans. The reason for this rule remained for a long time unexplained. It is
known, however, that some persons in Mediterranean countries suffered from haemo-
globinuria when they cameinto contact with these plants. This was termedfavismand
regarded as a peculiar form of hypersensitivity. Recent findings showed that this
sensitivity occurs only in those people whose erythrocytes lack the enzyme glucose-6-
phosphate dehydrogenase. These people also very often react to pamaquine, prima-
quine and other drugs with haemolysis. On the other hand, they are much more
resistant to infection with Plasmodium falciparum than others. In malarial districts
this is a reason fortheexpectation oflonger life and betterreproduction. The enzyme
deficiency occurs therefore more frequently in malarial areas. We see an 'inborn
error of metabolism' constituting an advantage when life is influenced by malaria
infections. Even nature can be successful by producing a genetic error. How many
errors may have been made in the development of homo sapiens?
The main pharmacological effects of 5-hydroxytryptamine were described in 1940
by Erspamer, at a time when the chemical structure was unknown and the compound
was called 'Enteramine'. In 1947, Page and his co-workers began to isolate a vaso-
constrictor and hypertensive agent from beef serum, arguing a possible significance
of this compound in hypertension. By using the rabbit ear as a test preparation for
vasoconstriction, they were successful in isolating serotonin, which is the same
substance as Erspamer's enteramine. This discovery very soon led us to forget that
serotonin is by no means apathogenetic factor in hypertension which was anticipated
at the very beginning of Page's research.
In 1962 Kirberger, working in Frankfurt at a hospital for the mentally ill, investi-
gatedthe5-hydroxyindolacetic acid(5-HIAA)excretionin alargenumberofpsychotic
patients. One of these patients excreted high amounts of 5-HIAA. Repeated esti-
mations showed a 3 or 4 days' cycle of very high and low values. This cycle was
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found to bear no correlation to any symptoms but rather to the days when visits
were allowed. At each-visit the patient's mother brought him a parcel ofnuts which
he liked very much. This small gift prompted the discovery that nuts contain high
amounts of 5-hydroxytryptamine. The planned experiments did not bring the result
expected, but a useful observation for all those who perform 5-HIAA estimations
in urine.
Examples of different kinds are widely scattered: Hahnemann is known as the
founder ofasystemofmedicaltreatmentcalled homeopathy. Formorethan acentury
it seemed to be ariddle thatmedicines in very high dilutions, free from any detectable
pharmacodynamic effect and-in the so called 'high potencies' probably free of any
active molecules-could relieve symptoms and pain from a patient. Certainly, many
drugs ofthe old allopaths were by no means better. Even today clouded evidence of
homeopathic medicines is sought by some. We know that beliefin these effects is an
error, but hardly a better and more prolonged successful trial of placebo effects
could be found.
Other examples can be found in various clinical disciplines: Barraquer, a Spanish
ophthalmologist, had a patient with a severe haemorrhagein the vitreous body ofthe
eye. Treatment was not possible and he thought as a last resort that injection of
chymotrypsin into the eye might dissolve the blood clot. The next day, he observed
no improvement but noted that the lens lay disconnected from its zonula fibres.
Therefore he dropped chymotrypsin into opened eyes, first in rabbits, then in man,
when he performed cataract operations, and found it thereafter to be extremely easy
to extract the lens. In this way the enzymatic zonulolysis was found, now mainly
performed by the use oftrypsin.
Vogl (1950) described thediscovery ofthemercurial diuretics when he was ayoung
doctor at the Wenckebach Clinic in Vienna in 1919. A patient with severe symptoms
of congenital syphilis should, 'ut aliquid fieri', be injected daily with salicylate of
mercury. Vogl had to write the prescription. But his prescription, a 10 per cent
solution of mercurial salicylate, could not be provided by the hospital pharmacy
becauseofitsinsolubilityinwater. Whilehewaswritinganewprescriptionacolleague
offered him a new mercurial antisyphilitic which he had received as a sample for
medical trial by mail that morning, under the proprietary name Novasurol. In this
immediate post-war period, the training of nurses was being carried out in this
clinic with scrupulous attention to detail, so scrupulous in fact that even urine was
collected daily from all patients, measured, and recorded on the patient's chart. In
this way the observation of the diuretic effect of Novasurol was made. Novasurol
was first assumed to have a curative effect on the syphilitic kidney. Thereafter the
diuretic action was also found in patients with non-syphilitic congestive heart failure.
It was an error to believe in an antisyphilitic effect ofNovasurol, but an unnecessary
recording of urine output and a lack of proper writing of prescriptions led to the
discovery ofits diuretic action.
For many years Amidopyrine has been a frequently used antipyretic drug in many
countries. It has been derived from Antipyrine. Antipyrine was synthesized by Knorr
in 1884. He first tried to synthesize a quinine-like compound. But the concept ofthe
quinineformula was wrong at that time. The assumed formula ofthe newcompound
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that he obtained was wrong too; Knorr thought it would be dimethylquinoline. The
clinician Filehne found that it had an excellent antipyretic action in man and the
compoundgotthenameantipyrin. Shortlythereafter, Knorrshowedthathissubstance
had a pyrazole ring and he published the correct structure.
Jancs6 and Jancso obtained in 1934 results which suggested that the trypanocidal
action ofsuramin (Germanin) depends on the inhibition ofcarbohydrate metabolism
in the trypanosomes by this chemotherapeutic agent. They assumed that a low
glucose level in blood could inhibit the growth oftrypanosomes. To investigate this,
they injected the hypoglycaemic agent Synthalin. The chemotherapeutic result was
excellent and they wrote in the summary of the paper: 'The first time a chemo-
therapeutic agent could be detected, not by incidence, but based on theoretical
assumptions'. Yorke, however, found shortly thereafter a very strong trypanocidal
action ofSynthalin in vitro. Synthalin, as is well known, has no effect on the glucose
content of blood in vitro! Other forms of hypoglycaemia were found to be without
effect on trypanosomes. We see in this example that the firmly stated theoretical
conclusion was an error and the pure accident that the researchers used Synthalin
and not Insulin forlowering the blood glucose level opened the successful way to the
investigation offurther trypanocidal substances.
In these days, the investigation of new drugs is carried out most carefully by the
large pharmaceutical firms. The industry performs long and careful tests to exclude
any kind ofdamage to patients and to diminish the danger ofhaving to withdraw an
expensively developed drug from the market. But even here, unexpected events can
occur.
Ethyl Biscoumacetate (Tromexan) was foundduring a screening ofanticoagulants
in rabbits withthe aim offinding short-actingcompounds. The action ofBiscoumace-
tate in man was also found to berelatively short. However, there is no direct relation
sincemetabolism in man isquitedifferent from thatin arabbit. In contrast to human
beings and rabbits which have a faster turnover, Biscoumacetate is metabolised at a
rate ofonly 3 percentperhourinthedog. Whatwould havehappened ifthescreening
had been done in dogs? We can deduce from such examples that some sort oferror
may, on the other hand, easily prevent new discoveries.
Unexpected findings are as possible today as a hundred years ago. Recently it has
been reported that thalidomide, given as a sedative to patients with severe lepra
reactions, produces a rapid improvement in all the cases treated. A short time ago,
Dr. Slama ofPrague, brought the eggs of an insect, Pyrrhocoris apterus, to Harvard
University for experimental studies on the developing larvae. But the larvae did not
develop normally as observed for many years in Prague. They changed to large size
formsduringthelastmetamorphosis and not to theinsect. Thecontainers in which the
larvae were kept during development were laid out with a sheet ofnewspaper as was
done previously in Prague. The investigators thereafter used newspaper of different
origins, including Science, Nature, The Times and The Wall Street Journal. They
found normal development of the larvae on European and Japanese papers and an
inhibition of growth on American papers. In this way an insect-growth-inhibiting
substance which occurs only in American pinewood was found.
These are some examples which I have selected. I am sure that others would be
163F. Lembeck
able to add some more, some better or some personal examples ofthis kind. I would
say that we should keep this in mind, even in a period where technical planning in
pharmacological and therapeutic research is an inevitable necessity and the only
sound way to approach research. In spite of elaborate plans, many unsuccessful
errors are included in the work ofus all.
Several ofthe above mentioned examples can certainly not be regarded simply as
'errors'. They are unexpected events or lucky accidents. Such things fall on the right
soil only when they come into the hands of experienced research workers who are
trained to work on a profound experimental basis, being experts in their fields and
possessing the full ability to evaluate an unexpected new result. All those research
workers I mentioned in my examples were indeed outstanding scientists.
Jacob von Uexkiill once referred in a discussion to the pessimistic epigram that
the truth of today is possibly no more than the error of tomorrow. Otto Koehler,
however, replied: 'No,-the truth of today is of no significance before tomorrow!'
I would like to add: 'An error oftoday can, although only very rarely, turn out to be
an unexpected success tomorrow'. We cannot search for it, but we must be aware of
its possible occurrence.
I conclude my remarks by citing a distinguished pharmacologist who mentioned
some oftheseexamples some years ago, and by referring to awell-known poet.
Sir John Gaddum wrote in his very clear manner: 'It will probably always be more
important to try a thing out than to argue about it.'
Erich Kastner gave us a comment in a much broader sense when he wrote:
Errors are quite good,
But only here and there,
Not everyone
Who sets out for India
Successfully discovers America.
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